Suppressing adipocyte inflammation promotes insulin resistance in mice. 2020

Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Obesity-induced insulin resistance is closely associated with chronic subclinical inflammation in white adipose tissue. However, the mechanistic involvement of adipocyte-derived inflammation under these disease conditions remains unclear. Our aim was to investigate the relative inflammation-related contributions of adipocytes and macrophages to insulin sensitivity. RIDα/β is an adenoviral protein complex that inhibits several inflammatory pathways, including TLR4, TNFα, and IL1β signaling. We generated novel mouse models with adipocyte-specific and macrophage-specific doxycycline (dox)-inducible RIDα/β-transgenic mice (RIDad and RIDmac mice, respectively). RIDα/β induction significantly reduced LPS-stimulated inflammatory markers, such as Tnf, Il1b, and Saa3 in adipose tissues. Surprisingly, RIDad mice had elevated levels of postprandial glucose and insulin and exhibited glucose intolerance and insulin resistance, even under chow-fed conditions. Moreover, the RIDad mice displayed further insulin resistance under obesogenic (high-fat diet, HFD) conditions despite reduced weight gain. In addition, under pre-existing obese and inflamed conditions on an HFD, subsequent induction of RIDα/β in RIDad mice reduced body weight gain, further exacerbating glucose tolerance, enhancing insulin resistance and fatty liver, and reducing adiponectin levels. This occurred despite effective suppression of the inflammatory pathways (including TNFα and IL1β). In contrast, RIDmac mice, upon HFD feeding, displayed similar weight gain, comparable adiponectin levels, and insulin sensitivity, suggesting that the inflammatory properties of macrophages did not exert a negative impact on metabolic readouts. RIDα/β expression and the ensuing suppression of inflammation in adipocytes enhanced adipose tissue fibrosis and reduced vascularization. Our novel findings further corroborate our previous observations suggesting that suppressing adipocyte inflammation impairs adipose tissue function and promotes insulin resistance, despite beneficial effects on weight gain.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty

Related Publications

Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
March 2009, Cell metabolism,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
January 2012, Diabetes, obesity & metabolism,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
September 2021, Biochemical and biophysical research communications,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
April 2024, Biomolecules,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
January 2010, Mediators of inflammation,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
March 2006, Biochemical and biophysical research communications,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
December 2010, Journal of cellular biochemistry,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
January 2018, Adipocyte,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
May 2013, European journal of pharmacology,
Qingzhang Zhu, and Yu A An, and Min Kim, and Zhuzhen Zhang, and Shangang Zhao, and Yi Zhu, and Ingrid Wernstedt Asterholm, and Christine M Kusminski, and Philipp E Scherer
October 2015, Endocrinology,
Copied contents to your clipboard!